RxSight (RXST) Enterprise Value (2020 - 2026)
RxSight's (RXST) quarterly Enterprise Value came in at -$418.2 million in Q1 2026, up 2.89% YoY from -$406.5 million in Q1 2025, and up 4.14% on a QoQ basis from -$436.3 million in Q4 2025.
RxSight (RXST) Enterprise Value (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Enterprise Value data on file, last reported at -$418.2 million in Q1 2026.
- Quarterly Enterprise Value rose 2.89% year-over-year to -$418.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$418.2 million (up 2.89% YoY) and the FY2025 annual result came in at -$436.3 million, down 83.91% from the prior year.
- Enterprise Value improved to -$418.2 million in Q1 2026, from -$436.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$143.8 million in Q1 2022 to a low of -$442.0 million in Q2 2024.
- A 5-year average of -$300.9 million and a median of -$253.9 million in 2023 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 32.11% in 2022, down 185.13% in 2022.
- Tracing RXST's Enterprise Value over 5 years: stood at -$199.8 million in 2022, then retreated by 22.49% to -$244.7 million in 2023, then climbed by 3.05% to -$237.2 million in 2024, then tumbled by 83.91% to -$436.3 million in 2025, then advanced by 4.14% to -$418.2 million in 2026.
- The last three Enterprise Value figures came in at -$418.2 million (Q1 2026), -$436.3 million (Q4 2025), and -$425.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | -467.80 Mn |
| 10 | RxSight | 254.75 Mn | -149.49 Mn | - | -404.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -404.25 Mn |
| Mar 31, 2026 | -418.21 Mn |
| Dec 31, 2025 | -436.28 Mn |
| Sep 30, 2025 | -425.38 Mn |
| Jun 30, 2025 | -414.64 Mn |
| Mar 31, 2025 | -430.64 Mn |
| Dec 31, 2024 | -237.22 Mn |
| Sep 30, 2024 | -237.12 Mn |
| Jun 30, 2024 | -442.04 Mn |
| Mar 31, 2024 | -210.22 Mn |
| Dec 31, 2023 | -244.69 Mn |
| Sep 30, 2023 | -253.92 Mn |
| Jun 30, 2023 | -285.44 Mn |
| Mar 31, 2023 | -291.24 Mn |
| Dec 31, 2022 | -199.77 Mn |
| Sep 30, 2022 | -211.87 Mn |
| Jun 30, 2022 | -232.07 Mn |
| Mar 31, 2022 | -143.85 Mn |
| Dec 31, 2021 | -294.27 Mn |
| Sep 30, 2021 | -265.34 Mn |